SB-061

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSB-061

Drug Alias NameSB-061

ClassificationBiologics

Mechanisms of ActionAggrecan core protein inhibitors

TargetsAggrecan core protein

Therapy Area/IndicationsOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEstonia

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSymic Bio

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSymic Oa Co

Active IndicationsN/A

Inactive IndicationsOsteoarthritis

ATC CodeN/A